259 related articles for article (PubMed ID: 25704025)
1. Mechanism of action of hypoglycemic effects of an intestine-specific inhibitor of microsomal triglyceride transfer protein (MTP) in obese rats.
Sakata S; Katsumi S; Mera Y; Kuroki Y; Nashida R; Kakutani M; Ohta T
J Pharmacol Sci; 2015 Jan; 127(1):103-8. PubMed ID: 25704025
[TBL] [Abstract][Full Text] [Related]
2. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, suppresses high fat diet-induced obesity and glucose intolerance in Sprague-Dawley rats.
Hata T; Mera Y; Tadaki H; Kuroki Y; Kawai T; Ohta T; Kakutani M
Diabetes Obes Metab; 2011 May; 13(5):446-54. PubMed ID: 21255216
[TBL] [Abstract][Full Text] [Related]
3. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, suppresses food intake and gastric emptying with the elevation of plasma peptide YY and glucagon-like peptide-1 in a dietary fat-dependent manner.
Hata T; Mera Y; Ishii Y; Tadaki H; Tomimoto D; Kuroki Y; Kawai T; Ohta T; Kakutani M
J Pharmacol Exp Ther; 2011 Mar; 336(3):850-6. PubMed ID: 21139060
[TBL] [Abstract][Full Text] [Related]
4. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, ameliorates impaired glucose and lipid metabolism in Zucker diabetic fatty rats.
Hata T; Mera Y; Kawai T; Ishii Y; Kuroki Y; Kakimoto K; Ohta T; Kakutani M
Diabetes Obes Metab; 2011 Jul; 13(7):629-38. PubMed ID: 21362121
[TBL] [Abstract][Full Text] [Related]
5. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, improves hyperglycemia and dyslipidemia independent of suppression of food intake in diabetic rats.
Sakata S; Ito M; Mera Y; Sasase T; Yamamoto H; Kakutani M; Ohta T
J Diabetes Res; 2014; 2014():803832. PubMed ID: 24895641
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of diethyl-2-({3-dimethylcarbamoyl-4-[(4'-trifluoromethylbiphenyl-2-carbonyl)amino]phenyl}acetyloxymethyl)-2-phenylmalonate (JTT-130), an intestine-specific inhibitor of microsomal triglyceride transfer protein.
Mera Y; Odani N; Kawai T; Hata T; Suzuki M; Hagiwara A; Katsushima T; Kakutani M
J Pharmacol Exp Ther; 2011 Feb; 336(2):321-7. PubMed ID: 20974698
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy of an intestine-specific inhibitor of microsomal triglyceride transfer protein and peroxisome proliferator-activated receptor γ agonist in diabetic rat.
Sakata S; Mera Y; Kuroki Y; Nashida R; Kakutani M; Ohta T
J Diabetes Res; 2014; 2014():890639. PubMed ID: 24772450
[TBL] [Abstract][Full Text] [Related]
8. JTT-501, a novel oral antidiabetic agent, improves insulin resistance in genetic and non-genetic insulin-resistant models.
Shibata T; Matsui K; Yonemori F; Wakitani K
Br J Pharmacol; 1998 Dec; 125(8):1744-50. PubMed ID: 9886766
[TBL] [Abstract][Full Text] [Related]
9. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, ameliorates lipid metabolism and attenuates atherosclerosis in hyperlipidemic animal models.
Mera Y; Kawai T; Ogawa N; Odani N; Sasase T; Miyajima K; Ohta T; Kakutani M
J Pharmacol Sci; 2015 Nov; 129(3):169-76. PubMed ID: 26598005
[TBL] [Abstract][Full Text] [Related]
10. The GLP-1 analogue exenatide improves hepatic and muscle insulin sensitivity in diabetic rats: tracer studies in the basal state and during hyperinsulinemic-euglycemic clamp.
Wu H; Sui C; Xu H; Xia F; Zhai H; Zhang H; Weng P; Han B; Du S; Lu Y
J Diabetes Res; 2014; 2014():524517. PubMed ID: 25580440
[TBL] [Abstract][Full Text] [Related]
11. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, reduces food preference for fat.
Mera Y; Hata T; Ishii Y; Tomimoto D; Kawai T; Ohta T; Kakutani M
J Diabetes Res; 2014; 2014():583752. PubMed ID: 24959597
[TBL] [Abstract][Full Text] [Related]
12. Canagliflozin potentiates GLP-1 secretion and lowers the peak of GIP secretion in rats fed a high-fat high-sucrose diet.
Hira T; Koga T; Sasaki K; Hara H
Biochem Biophys Res Commun; 2017 Oct; 492(2):161-165. PubMed ID: 28803984
[TBL] [Abstract][Full Text] [Related]
13. Acute activation of central GLP-1 receptors enhances hepatic insulin action and insulin secretion in high-fat-fed, insulin resistant mice.
Burmeister MA; Ferre T; Ayala JE; King EM; Holt RM; Ayala JE
Am J Physiol Endocrinol Metab; 2012 Feb; 302(3):E334-43. PubMed ID: 22094469
[TBL] [Abstract][Full Text] [Related]
14. GABA dramatically improves glucose tolerance in streptozotocin-induced diabetic rats fed with high-fat diet.
Sohrabipour S; Sharifi MR; Talebi A; Sharifi M; Soltani N
Eur J Pharmacol; 2018 May; 826():75-84. PubMed ID: 29391158
[TBL] [Abstract][Full Text] [Related]
15. A new antidiabetic agent (JTT-501) rapidly stimulates glucose disposal rates by enhancing insulin signal transduction in skeletal muscle.
Maegawa H; Obata T; Shibata T; Fujita T; Ugi S; Morino K; Nishio Y; Kojima H; Hidaka H; Haneda M; Yasuda H; Kikkawa R; Kashiwagi A
Diabetologia; 1999 Feb; 42(2):151-9. PubMed ID: 10064094
[TBL] [Abstract][Full Text] [Related]
16. Effect of magnesium sulfate administration to improve insulin resistance in type 2 diabetes animal model: using the hyperinsulinemic-euglycemic clamp technique.
Sohrabipour S; Sharifi MR; Sharifi M; Talebi A; Soltani N
Fundam Clin Pharmacol; 2018 Dec; 32(6):603-616. PubMed ID: 29869808
[TBL] [Abstract][Full Text] [Related]
17. Amylin improves the effect of leptin on insulin sensitivity in leptin-resistant diet-induced obese mice.
Kusakabe T; Ebihara K; Sakai T; Miyamoto L; Aotani D; Yamamoto Y; Yamamoto-Kataoka S; Aizawa-Abe M; Fujikura J; Hosoda K; Nakao K
Am J Physiol Endocrinol Metab; 2012 Apr; 302(8):E924-31. PubMed ID: 22275759
[TBL] [Abstract][Full Text] [Related]
18. Role of JTT-501, a new insulin sensitiser, in restoring impaired GLUT4 translocation in adipocytes of rats fed a high fat diet.
Terasaki J; Anai M; Funaki M; Shibata T; Inukai K; Ogihara T; Ishihara H; Katagiri H; Onishi Y; Sakoda H; Fukushima Y; Yazaki Y; Kikuchi M; Oka Y; Asano T
Diabetologia; 1998 Apr; 41(4):400-9. PubMed ID: 9562343
[TBL] [Abstract][Full Text] [Related]
19. Pioglitazone can ameliorate insulin resistance in low-dose streptozotocin and high sucrose-fat diet induced obese rats.
Ding SY; Shen ZF; Chen YT; Sun SJ; Liu Q; Xie MZ
Acta Pharmacol Sin; 2005 May; 26(5):575-80. PubMed ID: 15842776
[TBL] [Abstract][Full Text] [Related]
20. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
